6 voices in 10 minutes: When technology fails
DOI:
https://doi.org/10.47196/diab.v54i3Sup.348Keywords:
technology, patientsAbstract
6 voices in 10 minutes: Problems of glycemic control in children and adolescents
When technology fails
According to the Exchange, the use of technology has increased, the percentage of patients who achieve the target HbA1c in those under 18 years of age is 17% and there is an increase over time in HbA1c mainly in adolescents and young people. When does technology failure occur? There are psychosocial, socioeconomic, patient and family, and doctor barriers. What do we do? Work as an interdisciplinary team incorporating the patient and the family, where the three most important pillars are structured education, motivation and adherence, always considering that the objective of glycemic control must be individualized and with the technology acceptance model.
References
- Choudhary P, Campbell F, Joule N, Kar P; on behalf of Diabetes UK. Diabetes UK Position Statements A Type 1 divabetes technology pathway: consensus statement for the use of technology in Type 1 diabetes Diabet. Med. 36: 531–538 (2019).
- Kubiak T, Priesterroth L, Barnard-Kelly KD. PSAD Special Issue Paper Psychosocial aspects of diabetes technology Diabet. Med. 37, 448–454 (2020).
- Tanenbaum ML, Hanes SJ, Miller KM, Naranjo D, Bensen R, Hood KK. Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptakeand Potential Intervention Targets Diabetes Care 2017;40:181–187 | DOI: 10.2337/dc16-1536.
- Tanenbaum ML, Adams RN, Hanes SJ, et al. Optimal Use of Diabetes Devices: Clinician Perspectives on Barriers and Adherence to Device Use J Diabetes Sci Technol. 2017 May; 11(3): 484–492.
- Borges U, Kubiak T. Continuous Glucose Monitoring in Type 1 Diabetes Human Factors and Usage J Diabetes Sci Technol. 2016 May; 10(3): 633–639.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
